| 注册
首页|期刊导航|临床肝胆病杂志|一贯煎对M1型骨髓巨噬细胞治疗肝硬化大鼠模型效果的影响及其机制分析

一贯煎对M1型骨髓巨噬细胞治疗肝硬化大鼠模型效果的影响及其机制分析

宗梦瑶 慕永平 简迅 王丹阳 许燕楠 郑欣瑞 邢飞飞 陈高峰 陈佳美 刘平

临床肝胆病杂志2024,Vol.40Issue(8):1612-1619,8.
临床肝胆病杂志2024,Vol.40Issue(8):1612-1619,8.DOI:10.12449/JCH240817

一贯煎对M1型骨髓巨噬细胞治疗肝硬化大鼠模型效果的影响及其机制分析

Effect of Yiguan Decoction on the efficacy of M1 bone marrow-derived macrophages in treatment of liver cirrhosis rats and its mechanism

宗梦瑶 1慕永平 1简迅 1王丹阳 1许燕楠 1郑欣瑞 1邢飞飞 1陈高峰 1陈佳美 1刘平1

作者信息

  • 1. 上海中医药大学附属曙光医院,上海市中医药研究院肝病研究所,肝肾疾病病证教育部重点实验室,上海市中医临床重点实验室,上海 201203
  • 折叠

摘要

Abstract

Objective To investigate the effect and mechanism of Yiguan Decoction(YGJD)on the efficacy of M1 bone marrow-derived macrophages(M1-BMDMs)in the treatment of rats with liver cirrhosis induced by 2-AAF/CCl4.Methods BMDMs were isolated and induced into M1-BMDMs by lipopolysaccharide.A total of 50 male Wistar rats were randomly divided into normal group with 5 rats and model group with 45 rats.The rats for modeling were given subcutaneous injection of 50%CCl4 twice a week.Since week 7,the rats for modeling were randomly divided into model group(M group),YGJD group,M1-BMDM group,M1-BMDM+YGJD group,and sorafenib(SORA)group,and they were given subcutaneous injection of 30%CCl4 to maintain the progression of liver cirrhosis and intragastric administration of 2-AAF.CCR2 inhibitors were added to the drinking water,and each group was given the corresponding intervention.Related samples were collected at week 9.The rats were observed in terms of serum liver function parameters,liver pathology,hydroxyproline(Hyp)content in liver tissue,hepatic stellate cell activation,hepatic fibrosis and inflammation factors,and the expression levels of molecules associated with the Wnt signaling pathway.A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups.Results Compared with the M group,the M1-BMDM+YGJD group had significant reductions in the serum levels of alanine aminotransferase,aspartate aminotransferase,and total bilirubin(TBil)(all P<0.05)and a significant increase in the content of albumin(Alb)(P<0.05),and compared with the M1-BMDM group,the M1-BMDM+YGJD group had a significant reduction in the serum level of TBil(P<0.05)and a significant increase in the serum level of Alb(P<0.05).Compared with the M1-BMDM group,the M1-BMDM+YGJD group had significant reductions in the expression levels of CD68 and TNF-α(P<0.05).Compared with the M1-BMDM group,the M1-BMDM+YGJD group had significant reductions in Hyp content and Sirius red positive area(P<0.05).As for the non-canonical Wnt signaling pathway molecules,compared with the M1-BMDM group,the M1-BMDM+YGJD group had significantly lower mRNA and protein expression levels of Wnt5a(P<0.05)and mRNA expression level of Fzd2(P<0.05),as well as significant reductions in the mRNA expression levels of Wnt4,Wnt5b,and Fzd3(P<0.05),while there were no significant changes in the mRNA expression levels of the canonical Wnt signaling pathway molecules β-catenin,LRP5,LRP6,Fzd5,and TCF.Conclusion YGJD can enhance the therapeutic effect of M1-BMDMs on rats with liver cirrhosis induced by 2-AAF/CCl4,possibly by inhibiting the non-canonical Wnt5a/Fzd2 signaling pathway,which provides new ideas for the synergistic effect of traditional Chinese medicine on M1-BMDMs in the treatment of liver cirrhosis.

关键词

肝硬化/巨噬细胞/一贯煎/Wnt信号通路/大鼠,Wistar

Key words

Liver Cirrhosis/Macrophages/Yi Guan Jian/Wnt Signaling Pathway/Rats,Wistar

引用本文复制引用

宗梦瑶,慕永平,简迅,王丹阳,许燕楠,郑欣瑞,邢飞飞,陈高峰,陈佳美,刘平..一贯煎对M1型骨髓巨噬细胞治疗肝硬化大鼠模型效果的影响及其机制分析[J].临床肝胆病杂志,2024,40(8):1612-1619,8.

基金项目

国家自然科学基金面上项目(81874390) (81874390)

上海市科委自然科学基金面上项目(21ZR1464100) (21ZR1464100)

上海市科委2022年度"科技创新行动计划"生物医药科技支撑专项(22S11901700) (22S11901700)

上海市临床重点专科建设项目(shslczdzk01201) General Project of National Natural Science Foundation of China(81874390) (shslczdzk01201)

Shanghai Natural Science Foundation(21ZR1464100) (21ZR1464100)

Special Project for Biomedical Science and Technology Support of the"Science and Technology Innovation Action Plan"of Shanghai Science and Technology Commission in 2022(22S11901700) (22S11901700)

Shanghai Key Specialty of Traditional Chinese Clinical Medicine(shslczdzk01201) (shslczdzk01201)

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文